Profile: Vernalis PLC (VER.L)

VER.L on London Stock Exchange

69.25GBp
4:54am EDT
Change (% chg)

0.25p (+0.36%)
Prev Close
69.00p
Open
69.25p
Day's High
69.25p
Day's Low
69.25p
Volume
16,695
Avg. Vol
1,937,299
52-wk High
74.57p
52-wk Low
30.75p

Search Stocks
Vernalis plc is a United Kingdom-based research and development-stage pharmaceutical company. Vernalis has one marketed product and a portfolio of development and drug discovery programmes. Vernalis has nine active collaborations, four covering programmes in pre-clinical through to Phase II development and four active drug discovery collaborations. Its commercial pipeline includes CCP-01, CCP-05, CCP-06, CCP-07 and CCP-08. The Company operates in the United Kingdom, Rest of Europe, North America and Rest of the World.

Company Address

Vernalis PLC

100 Berkshire Place/Wharfedale R
WINNERSH     RG41 5RD
P: +44118.9380000
F: +44118.9380001

Company Web Links

Search Stocks